María Poveda Deltell

María Poveda Deltell is a seasoned professional in the life sciences investment sector, currently serving as Principal at Inveready since September 2018, where responsibilities include analyzing business investment opportunities and sourcing deal flow in Spain. In addition, María holds positions as a Board Member for Innerva Pharmaceuticals, S.L. and as a Board of Directors observer for several biotechnology companies including CONNECTA Therapeutics, MEDIBIOFARMA SL, and Ability Pharmaceuticals, SL, among others. María also contributes to academia as a professor for a master's program in Health Biotechnology at CESIF from October 2019 to July 2022. Educational qualifications include a Master's in Administration and Management of Biotechnology Companies from CESIF, a Master's in Biochemistry, Molecular Biology, and Biomedicine from Universidad Complutense de Madrid, and a degree in Biotechnology from Universidad Miguel Hernández de Elche.